About: Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 1999

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 1999 (uk) article scientifique publié en 1999 (fr) im Dezember 1999 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 1999 (ast) scientific article published on 01 December 1999 (en)
publication date	wds:Q73544347-2DA5EAD2-7574-41FF-B7D8-9BA53AF8BA24
publication date	1999-12-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q73544347-0035A35C-D4E9-4313-930F-CE3997FC3824 wds:Q73544347-261E729B-920F-4E70-BAD7-2E91A6C60056 wds:Q73544347-282CF925-3706-459E-AED3-487B5B567639 wds:Q73544347-2DC2BA85-DEDB-40B5-8EA4-9070D6F2D8B2 wds:Q73544347-3CF87F3C-0F82-4A10-BA9C-872C21C1D003 wds:Q73544347-41430E7D-6937-473A-99D6-6DA50B3C054A wds:Q73544347-55D546CB-91C4-4DD5-B487-986FBFC41A41 wds:Q73544347-78F853F1-0C66-4BEC-8801-1BC1B06ABEC8 wds:Q73544347-8126B14B-3620-48E8-B75C-FA372BD70DB7 wds:Q73544347-82AC1EE6-41C3-47BE-B673-F23D1B7C293C wds:Q73544347-883D9E33-4068-4ABE-9A69-FC3BFEFD4F79 wds:Q73544347-8D3538F4-FD3A-4D2C-9499-BC400893813D wds:Q73544347-9627584D-D313-4639-9896-EFDB1CF12FA3 wds:Q73544347-9729012E-E7A2-431A-B251-79A7BF7C35A6 wds:Q73544347-A08EA107-2458-4DC9-8050-DF0B76279F29 wds:Q73544347-C09FB52A-C451-4A6B-8E92-2D9CE26B3EBD wds:Q73544347-D96426AA-C0D1-46D5-AAB3-71C82C0559E8 wds:Q73544347-DC20B803-3B04-4A19-A284-A73A0BE1DCC1 wds:Q73544347-E341F8A1-D2DA-4189-8695-4B04A45E664B wds:Q73544347-E5C4821F-13CB-404A-9961-73D7D75C01AC wds:Q73544347-EF9FA92B-F7CB-458D-B2D8-AB688B992DF9
cites work	Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation Cycle control with oral contraceptives: A review of the literature Triphasic Randomized Clinical Trial: comparative frequency of intermenstrual bleeding Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons The antiestrogenic effect of cigarette smoking in women Compliance and oral contraceptives: a review Epidemiology of oral contraceptives and cardiovascular disease Maximum utilization of the life table method in analyzing survival Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation Modern oral contraceptives and cardiovascular disease. An open-label, multicenter, noncomparative safety and efficacy study of Mircette, a low-dose estrogen-progestin oral contraceptive. The Mircette Study Group Smoking and cycle control among oral contraceptive users Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction. Oral contraceptives and cycle control: a critical review of the literature Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol Phase III clinical trial with a new oral contraceptive containing 150 μg desogestrel and 20 μg ethinylestradiol A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG). A comparison of cycle control with monophasic levonorgestrel/ethinylestradiol 100 micrograms/20 micrograms versus triphasic norethindrone/ethinylestradiol 500-750-1000 micrograms/35 micrograms: a multicenter, randomized, open-label study. Statistical comparison of Pearl rates A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle contr
author name string	wds:Q73544347-37016B36-B295-40DB-80A4-67884B7CD099 wds:Q73544347-4198A381-462D-4E14-A10B-95CD3964C178 wds:Q73544347-B78A1421-942B-4605-ABD1-C33F3F212BA4
author name string	M J Rosenberg V Roy A Meyers
rdfs:label	Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations (en) Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations (nl)
skos:prefLabel	Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations (en) Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations (nl)
name	Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations (en) Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations (nl)
title	wds:Q73544347-1EF3BB4A-5694-4E0B-9118-E4BFC8AD39F7
title	Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations (en)
page(s)	wds:Q73544347-9AF69DDD-7CA4-4D39-9DEB-0CA27B04DDC0
page(s)	321-329
instance of	wds:Q73544347-7964E015-AC8C-4608-997F-4431787756AA
instance of	scholarly article
main subject	wds:Q73544347-962E8BCB-B5B7-49A8-8DB6-C6A172B84ADD
main subject	estrogen
PubMed ID	wds:Q73544347-F3B1DA46-7802-4840-BDA2-30C3301337C5
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10715366
PubMed ID	10715366
published in	wds:Q73544347-9C1867C3-B041-49DE-8F6F-18FDFA5FE074
published in	Contraception
issue	wds:Q73544347-A9DE2BEB-F092-46D5-B832-097462B73E46
volume	wds:Q73544347-869D818F-C88E-453D-9A0F-CCBC0558C541
issue	6
volume	60
DOI	wds:Q73544347-3C1E9202-262D-42B1-8BA4-29FACD5203F2
DOI	http://dx.doi.org/10.1016/S0010-7824(99)00109-2
DOI	10.1016/S0010-7824(99)00109-2
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73544347
is cites work of	Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism Physiologic and psychologic symptoms associated with use of injectable contraception and 20 microg oral contraceptive pills Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris Triphasic versus monophasic oral contraceptives for contraception Oral contraceptives: an update on health benefits and risks. Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial 20 µg versus >20 µg estrogen combined oral contraceptives for contraception Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials Triphasic versus monophasic oral contraceptives for contraception Choosing a combined oral contraceptive pill Treatment of acne with antiandrogens--an evidence-based review The influence of oral contraceptives on athletic performance in female athletes The emerging use of the 20-microg oral contraceptive Hormonal contraception in adolescents: special considerations Hormonal contraceptives: pharmacology tailored to women's health

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 176 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software